Discover the flourishing Europe CBD market projected to grow at a 24.57% CAGR by 2028. Legalization and increasing acceptance drive the market's expansion.

The Europe medical cannabis market size reached USD 2,586.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 12,652.9 Million by 2033, exhibiting a growth rate (CAGR) of 18.33% during 2025-2033. The market is poised for significant growth with increase in legalization and expanding therapeutic applications of the product and the rising patient demand for cannabis. Technological advancements in cultivation and extraction technologies, strategic partnerships and growing investment in research and development (R&D) are also contributing positively to the market growth.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the regional and country levels for 2025-2033. Our report has categorized the market based on species, derivative, application, end use and route of administration.

Europe CBD Product market size is USD 2344.56 million in 2024 and will expand at a compound annual growth rate (CAGR) of 14.7% from 2024 to 2031.

In Europe Cannabidiol Market, The European Industrial Hemp Association (EIHA) decided to take action after the Czech Ministry of Agriculture announced its intention to prohibit CBD-containing goods.

Snapshot img

Cannabidiol (CBD) Market Size 2025-2029

The cannabidiol (CBD) market size is forecast to increase by USD 56.5 billion, at a CAGR of 24.8% between 2024 and 2029.

The CBD market is experiencing significant growth, driven primarily by the ongoing legalization and regulatory changes surrounding cannabidiol. This evolving regulatory landscape presents both opportunities and challenges for market participants. On the one hand, increasing legalization allows for broader market access, fostering growth in various end-use industries such as food and beverages, cosmetics, and pharmaceuticals. On the other hand, the high cost of CBD products poses a significant challenge for consumer adoption and market penetration. The e-commerce industry plays a crucial role in the CBD market's growth, enabling brands to reach a wider audience and offering consumers the convenience of purchasing products online.
However, the high cost of CBD products, largely due to production and extraction expenses, may limit market expansion and create barriers for smaller players. To capitalize on market opportunities and navigate challenges effectively, companies must focus on optimizing production costs, exploring alternative extraction methods, and developing innovative, competitively priced products. By addressing these challenges and leveraging the growing demand for CBD, businesses can position themselves for success in this dynamic and rapidly evolving market.

What will be the Size of the Cannabidiol (CBD) Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The CBD market continues to evolve at an unprecedented pace, with new developments and trends emerging constantly. One of the most significant areas of growth is product differentiation, as companies strive to distinguish themselves in a crowded marketplace. CBD for inflammation is a popular application, with many brands offering various forms of CBD, including capsules, gummies, and topicals. Cannabis-derived CBD and hemp-derived CBD are two distinct categories, each with its unique advantages and challenges. The legal framework surrounding CBD is also a dynamic factor, with regulations evolving to accommodate the growing industry. Bioavailability is another critical aspect, with brands investing in research to improve the efficacy of their products through advanced formulation and delivery methods.

Consumer education is essential as the market becomes more complex, with various CBD types, such as broad spectrum and full spectrum, and different extraction methods, such as CO2 and ethanol. Brand awareness and loyalty are also crucial, with companies focusing on sustainable practices, transparency, and competitive pricing strategies to attract and retain customers. CBD's applications extend beyond human health, with the pet market showing significant growth. Pricing strategies vary, with some brands adopting a direct-to-consumer model, while others rely on retail channels and wholesale distribution. Regulations continue to shape the industry, with a focus on ensuring safety and quality, particularly in the areas of labeling, clinical trials, and intellectual property.

The CBD market's continuous evolution reflects the ongoing research and innovation in this field. From CBD oil to CBD vape products, CBD for anxiety to CBD for athletes, the potential applications of CBD are vast and ever-expanding. As the industry matures, it is essential to stay informed about the latest trends, regulations, and consumer preferences to remain competitive and succeed in this dynamic market.

How is this Cannabidiol (CBD) Industry segmented?

The cannabidiol (CBD) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Source

  Marijuana
  Hemp


Distribution Channel

  Offline
  Online


End-user

  Medical
  Personal use
  Wellness


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

.

By Source Insights

The marijuana segment is estimated to witness significant growth during the forecast period.

CBD, a non-psychoactive compound derived from the cannabis plant, has gained significant attention in the health and wellness industry due to its potential therapeutic benefits. Different forms of CBD products cater to various consumer preferences, including capsules, oils, topicals, edibles, vape products, and tinctures. The market for CBD continues to grow rapidly, driven by increasing consumer awareness and acceptance, favorable legal frameworks, and expanding product innovation.

The global cannabidiol (CBD) market is experiencing robust growth, projected to reach $567.2 million in 2025 and exhibiting a remarkable Compound Annual Growth Rate (CAGR) of 27.1% from 2025 to 2033. This expansion is driven by several factors. Increasing consumer awareness of CBD's potential therapeutic benefits for anxiety, pain relief, and sleep disorders fuels demand across diverse applications. The legalization and decriminalization of cannabis in various regions are significantly contributing to market accessibility. Furthermore, the expanding research and development efforts focused on CBD's efficacy and safety profile are further boosting investor confidence and driving market growth. The market's segmentation reflects this diverse application landscape, with significant contributions from the pharmaceuticals, food, and cosmetics industries. Hemp-derived CBD currently dominates the market due to its legal accessibility and lower cost compared to marijuana-derived CBD. However, the latter segment is expected to witness significant growth as regulations evolve. Key players such as Kazmira, KND Labs, and Aurora Cannabis are actively shaping the market through product innovation and strategic expansions. The geographic distribution of the CBD market reflects a concentration in North America, initially driven by early adoption and supportive regulatory environments in the United States and Canada. However, growing acceptance in Europe and the Asia-Pacific region, particularly in countries with emerging cannabis regulations, presents substantial untapped potential. While challenges remain, such as inconsistent regulations across different jurisdictions and concerns regarding product quality and standardization, the overall market outlook for CBD remains exceptionally positive, driven by continuous innovation, expanding consumer base, and the potential for broad therapeutic applications. The market is expected to continue its trajectory of strong growth well into the forecast period (2025-2033), benefiting from technological advancements and growing consumer understanding of CBD's diverse applications.

Medical cannabis made up the majority of the legal cannabis market in Europe in 2020. Sales of legal adult use cannabis totaled ***** million U.S. dollars in that year and are expected to grow to ***** million dollars by 2025.

The global cannabidiol (CBD) extract market is experiencing robust growth, driven by increasing consumer awareness of CBD's potential health benefits and its expanding applications in various industries. The market, while still relatively young, shows significant promise, with a projected Compound Annual Growth Rate (CAGR) allowing for substantial market expansion over the next decade. Factors such as the legalization of CBD in several regions, coupled with increasing research validating its therapeutic properties for conditions like anxiety, pain, and sleep disorders, are key drivers. Furthermore, the versatility of CBD extracts, enabling their use in diverse products like skincare, edibles, and supplements, fuels market expansion. While regulatory uncertainties and varying legal frameworks across different geographies pose challenges, the overall positive trajectory suggests a promising future for the CBD extract market. Leading companies like Aphria, Aurora Cannabis, Canopy Growth, Maricann, Organigram, Cronos Group, Tikun Olam, and Tilray are actively shaping this market landscape through innovation and expansion strategies. The market segmentation reveals various product forms and application areas, each exhibiting unique growth patterns. The regional distribution of the market shows significant traction in North America and Europe, reflecting the higher acceptance and legalization of CBD products in these regions. Future growth will likely be influenced by the continuing evolution of regulatory landscapes, advancements in CBD extraction technologies, and increasing consumer demand fueled by positive clinical research and brand awareness campaigns. The forecast period of 2025-2033 reveals a substantial market expansion. Assuming a conservative CAGR of 15% (a reasonable estimate based on current market trends), and a 2025 market size of $5 billion (a plausible figure considering current market valuations and growth projections), the market value would reach approximately $16 billion by 2033. This substantial increase highlights the considerable investment opportunities and potential for market disruption within the CBD extract sector. However, consistent monitoring of regulatory changes, emerging competitor dynamics, and evolving consumer preferences will be crucial for sustained success within this dynamic market.

The global cannabidiol (CBD) isolates market is experiencing robust growth, projected to reach a market size of $369 million in 2025, with a compound annual growth rate (CAGR) of 5.3% from 2025 to 2033. This expansion is driven by several factors. Increasing consumer awareness of CBD's potential health benefits, particularly in areas like pain management, anxiety relief, and sleep improvement, fuels demand across various applications. The burgeoning popularity of CBD-infused dietary supplements, food and beverages, and cosmetics contributes significantly to market growth. Furthermore, ongoing research into the therapeutic potential of CBD in pharmaceuticals is expected to unlock new avenues for market expansion in the coming years. The market is segmented by product type (CBD isolates, full-spectrum, broad-spectrum) and application (dietary supplements, food & beverages, e-cigarettes, cosmetics, pharmaceuticals). Competitive activity is also high, with numerous companies, including Kazmira, KND Labs, and Sequoya, vying for market share through product innovation and strategic partnerships. Growth is anticipated across all regions, but North America and Europe are currently the leading markets, reflecting higher consumer adoption rates and regulatory clarity in these areas. The market's trajectory is influenced by several dynamic trends. The increasing legalization and regulatory acceptance of CBD products in various jurisdictions are crucial factors. Simultaneously, the ongoing development of advanced extraction and purification techniques is leading to higher-quality, more cost-effective CBD isolates, boosting market accessibility. However, challenges remain. Regulatory inconsistencies across different regions pose an obstacle to global market penetration. Furthermore, concerns about product purity and standardization need to be addressed to maintain consumer trust and ensure the long-term sustainability of the market. Despite these challenges, the long-term outlook for the CBD isolates market remains positive, driven by sustained consumer interest and continuous scientific advancements in the field.

The North America, Europe & Asia Pacific Legal Cannabis Market is estimated to be valued at USD 36.2 billion in 2025 and is projected to reach USD 345.7 billion by 2035, registering a compound annual growth rate (CAGR) of 25.3% over the forecast period.

The Cannabidiol Market Report is Segmented by Source (Hemp and Marijuana), End Use (Pharmaceuticals, Wellness & Personal Use, and More), Product Form (Oils & Tinctures, Capsules & Softgels, and More), Distribution Channel (Hospital & Specialty Pharmacies, Retail Stores, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

In 2023, the medical cannabis market in Europe was valued at approximately 745 million U.S. dollars. In the following years, as more European countries will introduce legalization, the market is expected to increase significantly. Forecasts show that by 2027, the market could reach around 2.2 billion U.S. dollars.

Explore the burgeoning Cannabidiol (CBD) Extract market, valued at $56 million in 2025, with a steady 2.6% CAGR. Discover key drivers, applications in clinical labs and hospitals, and dominant products like oils and tinctures. Key players and regional market shares revealed.

The global cannabidiol (CBD) market size is projected to grow from USD 13.14 billion in 2025 to USD 51.43 billion by 2033, exhibiting a CAGR of 18.6%.
Report Scope:

The global Cannabidiol (CBD) Foods market is experiencing robust expansion, projected to reach a substantial market size of $6,500 million by 2025, with an anticipated Compound Annual Growth Rate (CAGR) of 12.5% through 2033. This significant growth is propelled by a growing consumer awareness of CBD's potential wellness benefits, particularly for stress reduction and improved sleep, alongside an increasing demand for natural and functional food products. The convenience store and online sale segments are leading the charge, offering readily accessible CBD-infused snacks, beverages, and supplements. This trend is further bolstered by evolving regulatory landscapes in key regions, which are gradually providing clearer guidelines for CBD product development and distribution, thereby fostering consumer trust and market legitimacy. The market's dynamism is further shaped by several key drivers, including advancements in extraction and formulation technologies that enhance CBD bioavailability and product efficacy. The growing acceptance of cannabis-derived products for therapeutic and recreational purposes is also a significant catalyst. However, challenges such as varying regulatory frameworks across different countries and ongoing consumer education efforts regarding CBD's safety and legality continue to influence the market's trajectory. Despite these restraints, the increasing integration of CBD into mainstream food and beverage products, coupled with significant investments from prominent companies like Canopy Growth, Curaleaf Holdings, and Charlotte's Web Holdings, underscores the immense potential and sustained growth expected in the CBD Foods sector over the forecast period. This report offers a deep dive into the burgeoning Cannabidiol (CBD) Foods market, analyzing its current landscape, future trajectory, and the key players shaping its evolution. We provide actionable insights derived from extensive industry research, catering to businesses seeking to understand and capitalize on this dynamic sector.

Discover the booming CBD market! Our comprehensive analysis reveals key trends, growth drivers, and regional insights for CBD oil, capsules, topicals & more. Explore market size projections, competitive landscape & top players from 2019-2033.

The global medicinal grade cannabis market is experiencing robust growth, driven by increasing legalization and acceptance of cannabis for therapeutic purposes, coupled with advancements in research and development of cannabis-based medications. The market, currently estimated at $15 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 18% from 2025 to 2033, reaching an estimated value of $60 billion by 2033. This significant expansion is fueled by several key factors. Rising prevalence of chronic pain, anxiety, and other conditions responsive to cannabinoid therapies is a major driver. Furthermore, the expanding range of cannabis-derived products, encompassing dronabinol, nabilone, nabiximols, and cannabidiol (CBD), caters to a diverse patient population and treatment needs. The market's segmentation across applications – hospitals, clinics, and pharmacies – reflects the increasing integration of medicinal cannabis into mainstream healthcare systems. Technological advancements in cultivation and extraction methods are also contributing to market growth by improving product quality and consistency. However, regulatory hurdles, varying legal frameworks across different regions, and concerns regarding the long-term effects of cannabis use continue to pose challenges to market expansion. Strict regulations on cannabis cultivation and distribution, coupled with the need for extensive clinical trials to establish efficacy and safety, can impede market penetration. The lack of standardized quality control protocols and inconsistent pricing across the market can also affect consumer confidence. Despite these constraints, the long-term outlook for the medicinal grade cannabis market remains exceptionally positive, fueled by ongoing research, evolving regulations, and a growing acceptance of cannabis as a viable therapeutic option. The increasing number of companies involved in the cultivation, processing, and distribution of medicinal cannabis further indicates its growing significance in the global healthcare landscape. This in-depth report provides a comprehensive overview of the burgeoning medicinal grade cannabis market, projected to reach $15 billion by 2028. We delve into concentration levels, market trends, key players, and future growth potential, providing actionable insights for businesses and investors. The report leverages extensive market research and data analysis to deliver a detailed picture of this dynamic industry. This report incorporates data from leading companies like Ultra Health, Canopy Growth, and Cresco Labs, offering crucial competitive intelligence.

Discover the booming Cannabidiol (CBD) market: A comprehensive analysis reveals a $1021 million market in 2025, projected to grow at 13.6% CAGR. Explore key drivers, trends, and regional insights into this rapidly expanding industry. Learn about leading companies and investment opportunities.

In Europe Medical Cannabis Market is projected to grow from USD 9.8 billion in 2025 to USD 29.4 billion by 2031, at a CAGR of 20.4%

The global Cannabidiol (CBD) distillate market, valued at $288 million in 2025, is projected to experience robust growth, driven by increasing consumer awareness of CBD's potential health benefits and its expanding applications across diverse sectors. The compound annual growth rate (CAGR) of 5.1% from 2025 to 2033 indicates a steadily expanding market, with significant potential for further expansion. Key drivers include the rising popularity of CBD in dietary supplements, food and beverages, and cosmetics, fueled by consumer demand for natural and alternative wellness solutions. The market segmentation, encompassing full-spectrum and broad-spectrum CBD distillates, caters to varying consumer preferences and product formulations. While regulatory hurdles and inconsistent quality control remain challenges, ongoing research and development are expected to mitigate these concerns, furthering market growth. The significant presence of established players like Kemin and emerging companies like EcoGen Biosciences highlights a dynamic competitive landscape. Geographic expansion, particularly in regions with burgeoning health and wellness markets, is anticipated to drive future market expansion. The North American market currently holds a significant share, attributable to early adoption and established regulatory frameworks (though still evolving), compared to other regions. However, increased regulatory clarity and growing consumer awareness in Europe and Asia-Pacific are likely to propel market expansion in these regions over the forecast period. The increasing demand for high-purity CBD distillates for pharmaceutical applications presents a substantial opportunity for future market growth, requiring continued investment in research and advanced extraction technologies. Furthermore, the development of innovative product formulations and marketing strategies tailored to specific consumer segments will play a crucial role in shaping the future trajectory of the CBD distillate market. The market is expected to witness consolidation as larger companies acquire smaller players, leading to increased economies of scale and product innovation.